We are live on ! Find out more
AWM

Avior Wealth Management Portfolio holdings

AUM $3.8B
1-Year Est. Return 23.28%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+23.28%
3 Year Est. Return
+66.02%
5 Year Est. Return
+68.67%
10 Year Est. Return
+243.27%
AUM
$2.15B
AUM Growth
+$502M
Cap. Flow
+$359M
Cap. Flow %
16.69%
Top 10 Hldgs %
26.23%
Holding
3,886
New
2,335
Increased
1,059
Reduced
234
Closed
48

Sector Composition

Rank Sector Weight
1 Miscellaneous 66.14%
2 Technology 7.87%
3 Financials 7.18%
4 Industrials 3.99%
5 Healthcare 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPRN icon
3601
Princeton Bancorp
BPRN
$288M
$30 ﹤0.01%
+1
New +$32
IBEX icon
3602
IBEX
IBEX
$499M
$30 ﹤0.01%
+2
New +$33
MGTX icon
3603
MeiraGTx Holdings
MGTX
$1.36B
$30 ﹤0.01%
+5
New +$32
OVID icon
3604
Ovid Therapeutics
OVID
$572M
$30 ﹤0.01%
+10
New +$33
SCPH
3605
DELISTED
scPharmaceuticals
SCPH
$30 ﹤0.01%
+6
New +$34
XFOR icon
3606
X4 Pharmaceuticals
XFOR
$419M
$30 ﹤0.01%
+1
New +$28
ALDX icon
3607
Aldeyra Therapeutics
ALDX
$92.9M
$29 ﹤0.01%
+9
New +$30
ATLC icon
3608
Atlanticus Holdings
ATLC
$1.41B
$29 ﹤0.01%
+1
New +$33
BLUE
3609
DELISTED
bluebird bio
BLUE
$29 ﹤0.01%
+1
New +$26
PEPG icon
3610
PepGen
PEPG
$213M
$29 ﹤0.01%
+2
New +$24
SMLR
3611
DELISTED
Semler Scientific
SMLR
$29 ﹤0.01%
+1
New +$42
PHLT
3612
DELISTED
Performant Healthcare Inc
PHLT
$29 ﹤0.01%
+10
New +$29
EVBN
3613
DELISTED
Evans Bancorp Inc
EVBN
$29 ﹤0.01%
+1
New +$30
MACK
3614
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$29 ﹤0.01%
+2
New +$28
AMLX icon
3615
Amylyx Pharmaceuticals
AMLX
$4.14B
$28 ﹤0.01%
+10
New +$131
GPGI
3616
GPGI Inc
GPGI
$3.84B
$28 ﹤0.01%
+5
New +$23
CRD.A icon
3617
Crawford & Co Class A
CRD.A
$622M
$28 ﹤0.01%
+3
New +$34
DSGN icon
3618
Design Therapeutics
DSGN
$954M
$28 ﹤0.01%
+7
New +$19
IGMS
3619
DELISTED
IGM Biosciences
IGMS
$28 ﹤0.01%
+3
New +$35
MP icon
3620
MP Materials
MP
$10.5B
$28 ﹤0.01%
2
OPI
3621
DELISTED
Office Properties Income Trust
OPI
$28 ﹤0.01%
+14
New +$48
PCYO icon
3622
Pure Cycle
PCYO
$275M
$28 ﹤0.01%
+3
New +$30
VLGEA icon
3623
Village Super Market
VLGEA
$644M
$28 ﹤0.01%
+1
New +$26
WLDN icon
3624
Willdan Group
WLDN
$1.34B
$28 ﹤0.01%
+1
New +$22
LOGC
3625
DELISTED
ContextLogic
LOGC
$28 ﹤0.01%
+5
New +$28

Similar funds

Avior Wealth Management's Q1 2024 Portfolio in Review

As of Q1 2024, Avior Wealth Management held 3,886 positions worth $2.15B, up 30% from $1.65B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Avior Wealth Management deployed $359M of net new capital in Q1 2024, opening 2,335 new positions and adding to 1,059 existing holdings. Its largest new stake was Zacks Small/Mid Cap ETF: 199,298 shares worth $6.31M.

By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, down from 71% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Schwab US Large-Cap Growth ETF, an estimated $12.7M trimmed.

  • Avior Wealth Management's largest Q1 2024 buy was Zacks Small/Mid Cap ETF: 199,298 shares worth $6.31M.
  • Avior Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $15.5M increase.
  • Avior Wealth Management's biggest Q1 2024 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $12.7M.
  • Avior Wealth Management fully exited Legend Biotech in Q1 2024, selling an estimated $446K.
  • Avior Wealth Management's ten largest holdings make up 26% of its $2.15B portfolio in Q1 2024.
  • Avior Wealth Management opened 2,335 new positions and closed 48 in Q1 2024.
  • Avior Wealth Management's portfolio value rose 30% quarter-over-quarter to $2.15B.

Based on Avior Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.